E. Moeller

发表

A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

J. Cuzick, A. Giuliano, S. Kjaer, 2015, The New England journal of medicine.

Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women

J. C. Reina, E. Moreira, E. Lazcano-Ponce, 2017, Papillomavirus research.

Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine

E. Moreira, Joshua Chen, E. Moeller, 2015, Human vaccines & immunotherapeutics.

Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials

J. Cuzick, A. Giuliano, S. Kjaer, 2016, Pediatrics.

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

J. Cuzick, A. Giuliano, S. Kjaer, 2017, The Lancet.

A 9-valent HPV vaccine against infection and intraepithelial Neoplasia in women

J. Cuzick, A. Giuliano, S. Kjaer, 2015 .

Immunogenicity and Safety of a 9-Valent HPV Vaccine

X. Castellsagué, P. van Damme, P. Pitisuttithum, 2015, Pediatrics.

Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries

S. Garland, P. Pitisuttithum, H. Yoshikawa, 2018, The Journal of infectious diseases.

Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine – A combined analysis of five phase III clinical trials

J. Cuzick, A. Giuliano, S. Kjaer, 2017, Papillomavirus research.

Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine

A. Giuliano, M. Penny, Joshua Chen, 2015, Human vaccines & immunotherapeutics.

9-Valent human papillomavirus vaccine: a review of the clinical development program

E. Moeller, A. Luxembourg, Erin Moeller, 2017, Expert review of vaccines.

Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population.

A. Giuliano, S. Kjaer, S. Garland, 2019, Gynecologic oncology.

Design of a large outcome trial for a multivalent human papillomavirus L1 virus-like particle vaccine.

Joshua Chen, O. Bautista, E. Moeller, 2015, Contemporary clinical trials.